Every 16 seconds one baby is stillborn. The Wellcome Leap In Utero program funds projects that investigate better ways to assess gestational development in utero.
In Utero is a $50M program with the goal of cutting stillbirth rates in half by creating scalable methods to measure, model and predict gestational development in utero. That amounts to more than two million stillborn babies globally every year. Stillbirths have long-lasting personal and psychological consequences for parents, as well as substantial costs for wider society.
While at IDE Group, I was the mechanical/industrial design lead on a novel foetal monitor project supported by the In Utero program, that our client took to clinical trial. Product development materials are confidential and protected under NDA.
Image: Wellcome Leap
